Skip to main content
. 2018 Sep 12;75(12):1225–1233. doi: 10.1001/jamapsychiatry.2018.2462

Table 3. Association of History of Depressive Symptoms, Self-reported Physician Diagnosis of Depression, and Antidepressant Use With Incident SLE in the NHS and NHS II, 1992-2013.

Variable SLE Cases, No. Person-Yearsa Hazard Ratio (95% CI)
Model 1b Model 2c
Depressive symptoms (MHI-5)
No depression (MHI-5 score ≥60) 99 2 793 212 1 [Reference] 1 [Reference]
Probable depression (MHI-5 score <60) 43 694 391 1.70 (1.18-2.44)d 1.60 (1.11-2.31)e
Diagnosis of depression
No diagnosis 59 2 148 617 1 [Reference] 1 [Reference]
Diagnosis 20 366 539 2.19 (1.29-3.71)d 1.91 (1.12-3.26)e
Antidepressant use
No use 93 2 703 408 1 [Reference] 1 [Reference]
Use 40 431 991 2.80 (1.94-4.05)f 2.47 (1.70-3.60)f
Sensitivity analysis 1, depressive symptoms with more stringent MHI-5 cutoff
No depression (MHI-5 score ≥52) 117 3 175 548 1 [Reference] 1 [Reference]
Probable depression (MHI-5 score <52) 22 219 142 2.29 (1.45-3.64)d 2.17 (1.37-3.46)d
Sensitivity analysis 2, censoring women at first antidepressant use
No depression 61 2 184 815 1 [Reference] 1 [Reference]
Depression diagnosis or MHI-5 score <60 26 452 061 2.11 (1.32-3.38)d 2.04 (1.27-3.26)d
Sensitivity analysis 3, association with antidepressant type
No antidepressant use 93 2 704 188 1 [Reference] 1 [Reference]
SSRI use 26 289 937 2.96 (1.88-4.64)f 2.63 (1.66-4.14)f
Tricyclic or other antidepressant use 12 118 695 3.19 (1.72-5.93)f 2.86 (1.53-5.31)f
Sensitivity analysis 4, stratified by dsDNA antibody status
Anti-dsDNA antibody–positive SLE
No depression 33 2 529 872 1 [Reference] 1 [Reference]
Depression 42 1 140 243 2.58 (1.66-3.99)f 2.28 (1.46-3.56)f
Anti-dsDNA antibody–negative SLE
No depression 36 2 529 748 1 [Reference] 1 [Reference]
Depression 34 1 140 158 2.50 (1.54-4.06)f 2.30 (1.41-3.75)f

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); dsDNA, double-stranded DNA; MHI-5, 5-item Mental Health Inventory; NHS, Nurses’ Health Study; SLE, systemic lupus erythematosus; SSRI, serotonin reuptake inhibitor.

a

Person-years differ in models because each measure was first queried in a different year; person-time prior to the first query was excluded.

b

Adjusted for race and age.

c

Adjusted for time-updated BMI, cigarette smoking, and oral contraceptive and postmenopausal hormone use.

d

P < .01.

e

P < .05.

f

P < .001.